As a pioneer of the biotechnology movement in the early 1980s, Genzyme has always been driven by cutting-edge science and a commitment to developing treatments for unmet medical needs. In this video, former CEO David Meeker, former CEO Henri Termeer, and patients share how Genzyme has continued to build on this foundation over the past three decades.
Focusing on uncommon and underserved medical conditions, our Rare Disease franchise is committed to empowering the lives of patients with rare diseases by offering sustainable, transformative healthcare options.
Our MS franchise is committed to being a long-term partner to the MS community by working to deliver scientific advancements that will have a significant impact on the unmet needs of people living with MS.
Expression of Hope is a global program of awareness and inspiration featuring works of art by the lysosomal storage disorder community. Expression of Hope gives those impacted by LSDs the opportunity to raise awareness of these rare genetic diseases. In collaboration with patient organizations around the world, the LSD community is encouraged to create original pieces of art that explore their experiences of living with an LSD. www.expressionofhope.com